Owners, management and financials
CVR: 32090168
Secondary names: C.O.P A/S, COP A/S
EUR 1,210,782
Gross profit
Net result: EUR 237,447
CHR. OLESEN A/S (50-66,65%), SVVF UG & Co. KG (50-66,65%)
CVR · view owners
Christian Dam Olesen, Mads Christian Olesen
1 more in management
Board: Tobias Facklam (chair) and 2 members
CVR · view management
Active
Founded 31 March 2009
CVR · view overview
2 employees
CVR · 2026
Director registered: Mads Christian Olesen
CVR · 26/01/2026
View the full event history
CHR. OLESEN PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Gentofte, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Christian Dam Olesen, Mads Christian Olesen and Phillip Christian Dam Quitzau Olesen. The board consists of Tobias Facklam (chair), Christian Dam Olesen and Fabian von Volkmann. The company is owned by CHR. OLESEN A/S and SVVF UG & Co. KG. The company has 2 employees (2026). In 2025, the company reported a gross profit of EUR 1,210,782 and a net result of EUR 237,447 compared with EUR 70,556 the year before. Equity in the 2025 report amounted to EUR 1,744,707.
Source: annual report 2025, Danish Business Authority
The financial health of CHR. OLESEN PHARMACEUTICALS A/S appears robust, with a steady increase in gross profit and profitability over recent years. Gross profit rose from 740,306 EUR in 2021 to 1,210,782 EUR in 2025, while profit peaked at 465,238 EUR in 2022 before stabilizing at 237,447 EUR in 2025. The company's equity has shown consistent growth, reaching 1,744,707 EUR in 2025, indicating a strong capital position. However, the absence of disclosed revenue figures raises concerns about transparency and overall market performance within the pharmaceuticals wholesale sector. Overall, the company demonstrates solid margins and a favorable equity trajectory, positioning it well within the industry.
AI-generated summary · Generated 13/08/2026
Selskabets formål er at drive virksomhed ved handel og distribution af aktive farmaceutiske stoffer til human brug.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/10/2024 – 30/09/2025 | 1.2 mio. EUR | 237 t. EUR | 11.4 mio. EUR | 1.7 mio. EUR | 3 | |
| 202401/10/2023 – 30/09/2024 | 916 t. EUR | 71 t. EUR | 10.8 mio. EUR | 1.6 mio. EUR | 3 | |
| 202301/10/2022 – 30/09/2023 | 1.4 mio. EUR | 421 t. EUR | 14.1 mio. EUR | 1.7 mio. EUR | 5 | |
| 202201/10/2021 – 30/09/2022 | 1.2 mio. EUR | 465 t. EUR | 15 mio. EUR | 1.3 mio. EUR | 2 | |
| 202101/10/2020 – 30/09/2021 | 740 t. EUR | 251 t. EUR | 13 mio. EUR | 850 t. EUR | 1 | |
| 202001/10/2019 – 30/09/2020 | 1 mio. EUR | 455 t. EUR | 9.4 mio. EUR | 599 t. EUR | 1 | |
| 201901/10/2018 – 30/09/2019 | 1.1 mio. EUR | 475 t. EUR | 8.4 mio. EUR | 444 t. EUR | 1 | |
| 201801/10/2017 – 30/09/2018 | 468 t. EUR | 96 t. EUR | 6.9 mio. EUR | -31 t. EUR | 1 | |
| 201701/10/2016 – 30/09/2017 | 529 t. EUR | 128 t. EUR | 3.5 mio. EUR | -126 t. EUR | 1 | |
| 201601/10/2015 – 30/09/2016 | 395 t. EUR | 21 t. EUR | 4.2 mio. EUR | -254 t. EUR | 1 | |
| 201501/10/2014 – 30/09/2015 | 326 t. EUR | -130 t. EUR | 3.6 mio. EUR | -295 t. EUR | 1 | |
| 201401/10/2013 – 30/09/2014 | 125 t. EUR | 3.1 mio. EUR | 4.7 mio. EUR | -212 t. EUR | 1 | |
| 201301/10/2012 – 30/09/2013 | 734 t. EUR | -1.3 mio. EUR | 13.4 mio. EUR | -3.3 mio. EUR | 2 |
Compared to 404 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of CHR. OLESEN PHARMACEUTICALS A/S is 32090168.
CHR. OLESEN PHARMACEUTICALS A/S is owned by CHR. OLESEN A/S and SVVF UG & Co. KG.
The management of CHR. OLESEN PHARMACEUTICALS A/S consists of Christian Dam Olesen, Mads Christian Olesen and Phillip Christian Dam Quitzau Olesen.
The board of CHR. OLESEN PHARMACEUTICALS A/S consists of Tobias Facklam, Christian Dam Olesen and Fabian von Volkmann, with Tobias Facklam as chair.
In 2025, CHR. OLESEN PHARMACEUTICALS A/S reported a gross profit of EUR 1,210,782.
CHR. OLESEN PHARMACEUTICALS A/S had 2 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
CHR. OLESEN PHARMACEUTICALS A/S has published its annual report for 2025. Gross profit came to DKK 1,210,782, and the net result was DKK 237,447.
As of January 26, 2026, Christian Dam Olesen has joined the board of directors of CHR. OLESEN PHARMACEUTICALS A/S.
As of January 26, 2026, Fabian von Volkmann has joined the board of directors of CHR. OLESEN PHARMACEUTICALS A/S.
As of January 26, 2026, Mads Christian Olesen has left the board of directors of CHR. OLESEN PHARMACEUTICALS A/S.
As of January 26, 2026, Hans Schröder-von Volkmann has left the board of directors of CHR. OLESEN PHARMACEUTICALS A/S.
As of January 26, 2026, Mads Christian Olesen is registered as director of CHR. OLESEN PHARMACEUTICALS A/S.
As of January 26, 2026, Christian Dam Olesen is registered as adm. dir. of CHR. OLESEN PHARMACEUTICALS A/S.
As of January 25, 2026, Mads Christian Olesen has stepped down as adm. dir. of CHR. OLESEN PHARMACEUTICALS A/S.
As of January 25, 2026, Christian Dam Olesen has stepped down as director of CHR. OLESEN PHARMACEUTICALS A/S.
CHR. OLESEN PHARMACEUTICALS A/S has published its annual report for 2024. Gross profit came to DKK 915,966, and the net result was DKK 70,556.
As of November 25, 2024, is registered as an owner of CHR. OLESEN PHARMACEUTICALS A/S with an ownership share of 50%.
CHR. OLESEN PHARMACEUTICALS A/S has published its annual report for 2023. Gross profit came to DKK 1,382,569, and the net result was DKK 421,191.
As of March 15, 2023, Phillip Christian Dam Quitzau Olesen is registered as director of CHR. OLESEN PHARMACEUTICALS A/S.
CHR. OLESEN PHARMACEUTICALS A/S has published its annual report for 2022. Gross profit came to DKK 1,215,287, and the net result was DKK 465,238.
As of November 8, 2022, Christian Dam Olesen is registered as director of CHR. OLESEN PHARMACEUTICALS A/S.
CHR. OLESEN PHARMACEUTICALS A/S has published its annual report for 2021. Gross profit came to DKK 740,306, and the net result was DKK 251,103.
CHR. OLESEN PHARMACEUTICALS A/S has published its annual report for 2020. Gross profit came to DKK 1,026,370, and the net result was DKK 454,764.
CHR. OLESEN PHARMACEUTICALS A/S has published its annual report for 2019. Gross profit came to DKK 1,069,171, and the net result was DKK 474,910.
CHR. OLESEN PHARMACEUTICALS A/S has published its annual report for 2018. Gross profit came to DKK 467,859, and the net result was DKK 95,831.
CHR. OLESEN PHARMACEUTICALS A/S has published its annual report for 2017. Gross profit came to DKK 528,524, and the net result was DKK 127,982.
CHR. OLESEN PHARMACEUTICALS A/S has published its annual report for 2016. Gross profit came to DKK 395,285, and the net result was DKK 21,094.
As of December 22, 2016, Hans Schröder-von Volkmann has joined the board of directors of CHR. OLESEN PHARMACEUTICALS A/S.
As of December 22, 2016, Tobias Facklam has joined the board of directors of CHR. OLESEN PHARMACEUTICALS A/S.
As of December 22, 2016, Svend Aage Johansen has left the board of directors of CHR. OLESEN PHARMACEUTICALS A/S.
As of December 22, 2016, Jens H Thorsen has left the board of directors of CHR. OLESEN PHARMACEUTICALS A/S.
As of October 1, 2016, CHR. OLESEN A/S is registered as an owner of CHR. OLESEN PHARMACEUTICALS A/S with an ownership share of 50%.
CHR. OLESEN PHARMACEUTICALS A/S has published its annual report for 2015. Gross profit came to DKK 325,587, and the net result was DKK -130,467.
As of March 1, 2015, Jens H Thorsen has joined the board of directors of CHR. OLESEN PHARMACEUTICALS A/S.
As of March 1, 2015, Hans-Hermann Will has left the board of directors of CHR. OLESEN PHARMACEUTICALS A/S.
CHR. OLESEN PHARMACEUTICALS A/S has published its annual report for 2014. Gross profit came to DKK 125,269, and the net result was DKK 3,124,775.
As of September 30, 2014, Hans-Hermann Will has joined the board of directors of CHR. OLESEN PHARMACEUTICALS A/S.
As of May 23, 2014, Mads Christian Olesen has joined the board of directors of CHR. OLESEN PHARMACEUTICALS A/S.
As of May 23, 2014, Allan Ardensø has left the board of directors of CHR. OLESEN PHARMACEUTICALS A/S.
As of May 23, 2014, Mads Christian Olesen is registered as adm. dir. of CHR. OLESEN PHARMACEUTICALS A/S.
As of May 23, 2014, Svend Aage Johansen has stepped down as adm. dir. of CHR. OLESEN PHARMACEUTICALS A/S.
CHR. OLESEN PHARMACEUTICALS A/S has published its annual report for 2013. Gross profit came to DKK 733,894, and the net result was DKK -1,305,001.
As of December 17, 2013, Allan Ardensø has joined the board of directors of CHR. OLESEN PHARMACEUTICALS A/S.
As of December 17, 2013, Terje Aarbogh has left the board of directors of CHR. OLESEN PHARMACEUTICALS A/S.
As of December 17, 2013, Svend Aage Johansen is registered as adm. dir. of CHR. OLESEN PHARMACEUTICALS A/S.
As of December 17, 2013, Terje Aarbogh has stepped down as adm. dir. of CHR. OLESEN PHARMACEUTICALS A/S.
CHR. OLESEN PHARMACEUTICALS A/S has published its annual report for 2012.
As of May 1, 2012, Terje Aarbogh has joined the board of directors of CHR. OLESEN PHARMACEUTICALS A/S.
As of May 1, 2012, Allan Ardensø has left the board of directors of CHR. OLESEN PHARMACEUTICALS A/S.
As of May 1, 2012, Terje Aarbogh is registered as adm. dir. of CHR. OLESEN PHARMACEUTICALS A/S.
As of May 1, 2012, Svend Aage Johansen has stepped down as adm. dir. of CHR. OLESEN PHARMACEUTICALS A/S.
As of July 1, 2011, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of CHR. OLESEN PHARMACEUTICALS A/S.
As of July 1, 2011, A/S PSE NR. 4820 has stepped down as auditor of CHR. OLESEN PHARMACEUTICALS A/S.
As of January 20, 2011, Allan Ardensø has joined the board of directors of CHR. OLESEN PHARMACEUTICALS A/S.
As of January 20, 2011, Jens Havskov Thorsen has left the board of directors of CHR. OLESEN PHARMACEUTICALS A/S.
As of March 31, 2009, A/S PSE NR. 4820 has been appointed auditor of CHR. OLESEN PHARMACEUTICALS A/S.
As of March 31, 2009, Svend Aage Johansen has joined the board of directors of CHR. OLESEN PHARMACEUTICALS A/S.
As of March 31, 2009, Jens Havskov Thorsen has joined the board of directors of CHR. OLESEN PHARMACEUTICALS A/S.
As of March 31, 2009, Svend Aage Johansen is registered as adm. dir. of CHR. OLESEN PHARMACEUTICALS A/S.
CHR. OLESEN PHARMACEUTICALS A/S was founded on March 31, 2009.
Companies in the same industry and area
CVR 27648568
CVR 39463989
CVR 44646021
CVR 27299032
CVR 36928638
